Stratify Genomics' flagship test, Prompt, is a major advancement in evaluating a man’s genetic predisposition to prostate cancer. This simple test, performed with a cheek swab sample, at any age, can help men know their individual risk for prostate cancer and may identify high-risk men who might benefit most from prostate cancer screening.
| Website | http://stratifygenomics.com |
| Employees | 5 (0 on RocketReach) |
| Technologies |
G Suite
,
Gmail
,
GoDaddy DNS
+1 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Genetic Predisposition, Prostate Health, Dna Testing, Men's Health, Cancer Genetics, At Home Dna Test, Cancer Risk Assessment, Early Detection, Genomic Testing, Risk Assessment Tools, Personalized Medicine, Disease Prediction, Genetic Screening, Genetic Health, Precision Oncology, Health Diagnostics |
| Competitors | Quest Diagnostics, Tempus Labs, Inc., National Cancer Institute (NCI), Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Caris Life Sciences, Invitae, NantHealth +50 more (view full list) |
Looking for a particular Stratify Genomics employee's phone or email?
Stratify Genomics is based in San Diego, California.